Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT00577278
Title A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Age Groups: adult
Covered Countries USA

No variant requirements are available.